PCM
FMS icon

Prelude Capital Management’s Fresenius Medical Care FMS Stock Holding History

Prelude Capital Management’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,400
Closed -$790K – 1979
2014
Q3 		$790K Buy
+11,400
New +$393K 0.11% 224
2013
Q3 		– Sell
-6,200
Closed -$219K – 1749
2013
Q2 		$219K Buy
+6,200
New +$216K 0.05% 432

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Prelude Capital Management's FMS Position: Q4 2022 in Review

Prelude Capital Management sold out of Fresenius Medical Care (FMS) in Q4 2022, closing a stake of 46,141 shares — an estimated $648K sold.

Prelude Capital Management first reported a position in FMS in Q2 2013 and held it in 7 quarters. The position peaked at $1.26M in Q3 2013. 155 funds tracked by Wall St. Rank hold FMS as of Q4 2022.

  • Prelude Capital Management reported no remaining Fresenius Medical Care position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 46,141 Fresenius Medical Care shares in Q4 2022, an estimated $648K.
  • Prelude Capital Management first reported a position in Fresenius Medical Care in Q2 2013 and held it in 7 quarters.
  • Prelude Capital Management's Fresenius Medical Care position peaked at $1.26M in Q3 2013.
  • 155 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.